Authors

Latest:

Oncologists Must Help Patients Overcome Fear of Genetic Testing to Uncover Cancer Risks

In the current digital age, where all-too-personal information flows from Facebook and Twitter, it seems that the health information available through the process of genetic testing would be an idea welcomed by most of the public.

Saurabh Chhabra, MD, MS

Latest:

Dr. Chhabra on Impactful Advances in Relapsed/Refractory Multiple Myeloma

Saurabh Chhabra, MD, MS, assistant professor at the Medical College of Wisconsin, discusses the most impactful advances made in relapsed/refractory multiple myeloma.

Science

Science University

Sciences Center

Scott A. Soefje, PharmD, MBA, BCOP

Latest:

Higher Incidence, New Therapies Add to Cost of Treating Advanced Pancreatic Cancer

Pancreatic cancer is one of the few cancers that is on the rise, and this means that the overall cost of treating this disease is also climbing.

Scott D. Rowley, MD

Latest:

Evolving Strategies Using Hematopoietic Stem Cell Transplantation in Diffuse Large B-Cell Non-Hodgkin Lymphoma

Diffuse large B-cell non-Hodgkin lymphoma is typically a chemotherapy-sensitive malignancy, justifying dose-intense therapy with hematopoietic stem cell transplantation for patients unlikely to achieve cure with standard-dose regimens.

Scott Eggener, MD

Latest:

Dr. Eggener on PSA-Based Screening in Early-Stage Prostate Cancer

Scott Eggener, MD, associate professor of Surgery, Urologic Oncology, at the University of Chicago Medicine, discusses his views on PSA-based screening and how to appropriately use it for patients with early-stage prostate cancer. Eggier shared these thoughts during the 2016 OncLive State of the Science Summit on GU and Prostate Cancer.

Scott Gettinger, MD

Latest:

Dr. Gettinger on Lung Cancer Immunotherapies

Scott Gettinger, MD, associate professor of medicine (medical oncology), Yale School of Medicine, explains the development of immunotherapies in lung cancer.

Scott Glaser, MD

Latest:

Dr. Glaser on Managing Radiation-Induced AEs in Early Breast Cancer

Scott Glaser, MD, assistant clinical professor of radiation oncology, City of Hope, discusses strategies for managing radiation-induced adverse events in patients with early-stage breast cancer.

Scott H. Okuno, MD

Latest:

The Use of Tyrosine Kinase Inhibitors for Gastrointestinal Stromal Tumors (GIST)

In this review article, the author discusses the use of tyrosine kinase inhibitors in the management of patients with gastrointestinal stromal tumors.

Scott Huntington, MD, MPH, MSc, Yale University

Scott Huntington, MD, MPH, MSc, Yale University School of Medicine

Scott J. Antonia, MD, PhD

Latest:

Dr. Antonia on Investigational Immunotherapy Combinations in Stage III NSCLC

Scott J. Antonia, MD, PhD, instructor, Duke University School of Medicine, member, Duke Cancer Institute, discusses investigational immunotherapy combinations in stage III non–small cell lung cancer (NSCLC).

Scott J. Swanson

Latest:

Dr. Swanson on Treating Multifocal Lung Cancer

Scott J. Swanson, MD, co-director of Minimally Invasive Surgery and chief surgical officer at Brigham and Women’s Hospital, professor of Surgery at Harvard Medical School, discusses treating multifocal lung cancer.

Scott J. Swanson, MD

Latest:

Dr. Swanson on Surgical Choices for Multifocal Lung Cancer

Scott Kopetz, MD, PhD, FACP

Scott Kopetz, MD, PhD, FACP, Deputy Chair for Translational Research, Department of Gastrointestinal (GI) Medical Oncology, Professor, Department of Gastrointestinal (GI) Medical Oncology and Leader, Department of Cancer Center Support Grant, GI Program, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.

Latest:

Advances in ctDNA Testing Guide Clinical Decision-Making in GI Cancer Management: With Scott Kopetz, MD, PhD, FACP

Dr Kopetz discusses the value of ctDNA assays, trials that have shown prognostic implications with this type of assay, and the future of ctDNA research.

Scott Kopetz, MD, PhD, FACP, The University of Texas MD Anderson Cancer Center

Scott Kopetz, MD, PhD MD Anderson Cancer Center

Scott Kopetz, MD, PhD, The University of Texas MD Anderson Cancer Center